Fatty acid metabolism, 3,2-trans-enoyl-CoA isomerase, mitochondrial
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I708
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006631 | fatty acid metabolic process | 4 | 2 |
GO:0006635 | fatty acid beta-oxidation | 6 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009062 | fatty acid catabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016042 | lipid catabolic process | 4 | 2 |
GO:0016054 | organic acid catabolic process | 4 | 2 |
GO:0019395 | fatty acid oxidation | 5 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0030258 | lipid modification | 4 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
GO:0034440 | lipid oxidation | 5 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044242 | cellular lipid catabolic process | 4 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0044282 | small molecule catabolic process | 3 | 2 |
GO:0046395 | carboxylic acid catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 19 |
GO:0004165 | delta(3)-delta(2)-enoyl-CoA isomerase activity | 5 | 12 |
GO:0016853 | isomerase activity | 2 | 19 |
GO:0016860 | intramolecular oxidoreductase activity | 3 | 12 |
GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 4 | 12 |
GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 5 | 4 |
GO:0016491 | oxidoreductase activity | 2 | 4 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 4 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 4 |
GO:0004300 | enoyl-CoA hydratase activity | 5 | 2 |
GO:0016829 | lyase activity | 2 | 2 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 2 |
GO:0016836 | hydro-lyase activity | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.249 |
CLV_NRD_NRD_1 | 340 | 342 | PF00675 | 0.536 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.249 |
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.518 |
CLV_PCSK_PC1ET2_1 | 54 | 56 | PF00082 | 0.518 |
CLV_PCSK_PC7_1 | 292 | 298 | PF00082 | 0.227 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.296 |
DEG_APCC_DBOX_1 | 296 | 304 | PF00400 | 0.234 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.579 |
DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.684 |
DOC_CYCLIN_RxL_1 | 236 | 247 | PF00134 | 0.245 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 327 | 333 | PF00134 | 0.373 |
DOC_PP2B_LxvP_1 | 219 | 222 | PF13499 | 0.322 |
DOC_PP2B_LxvP_1 | 281 | 284 | PF13499 | 0.320 |
DOC_PP4_FxxP_1 | 166 | 169 | PF00568 | 0.248 |
DOC_PP4_FxxP_1 | 63 | 66 | PF00568 | 0.426 |
DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.208 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.761 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.239 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.222 |
DOC_WW_Pin1_4 | 244 | 249 | PF00397 | 0.248 |
DOC_WW_Pin1_4 | 319 | 324 | PF00397 | 0.208 |
LIG_14-3-3_CanoR_1 | 11 | 17 | PF00244 | 0.526 |
LIG_14-3-3_CanoR_1 | 279 | 284 | PF00244 | 0.350 |
LIG_14-3-3_CanoR_1 | 29 | 34 | PF00244 | 0.496 |
LIG_APCC_ABBA_1 | 100 | 105 | PF00400 | 0.254 |
LIG_BIR_III_2 | 58 | 62 | PF00653 | 0.563 |
LIG_deltaCOP1_diTrp_1 | 158 | 166 | PF00928 | 0.248 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.273 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.626 |
LIG_FHA_1 | 315 | 321 | PF00498 | 0.237 |
LIG_LIR_Apic_2 | 165 | 169 | PF02991 | 0.247 |
LIG_LIR_Apic_2 | 62 | 66 | PF02991 | 0.455 |
LIG_LIR_Gen_1 | 101 | 111 | PF02991 | 0.250 |
LIG_LIR_Gen_1 | 155 | 163 | PF02991 | 0.223 |
LIG_LIR_Gen_1 | 278 | 284 | PF02991 | 0.248 |
LIG_LIR_Gen_1 | 298 | 304 | PF02991 | 0.091 |
LIG_LIR_Gen_1 | 313 | 323 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 101 | 106 | PF02991 | 0.250 |
LIG_LIR_Nem_3 | 158 | 163 | PF02991 | 0.239 |
LIG_LIR_Nem_3 | 278 | 283 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 313 | 319 | PF02991 | 0.337 |
LIG_LYPXL_SIV_4 | 273 | 281 | PF13949 | 0.389 |
LIG_PCNA_PIPBox_1 | 326 | 335 | PF02747 | 0.320 |
LIG_PCNA_yPIPBox_3 | 326 | 339 | PF02747 | 0.271 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.248 |
LIG_Pex14_2 | 315 | 319 | PF04695 | 0.350 |
LIG_SH2_CRK | 229 | 233 | PF00017 | 0.231 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.231 |
LIG_SH2_STAP1 | 311 | 315 | PF00017 | 0.235 |
LIG_SH2_STAT3 | 28 | 31 | PF00017 | 0.558 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 332 | 335 | PF00017 | 0.296 |
LIG_SH3_3 | 138 | 144 | PF00018 | 0.389 |
LIG_SH3_3 | 217 | 223 | PF00018 | 0.340 |
LIG_SH3_3 | 317 | 323 | PF00018 | 0.283 |
LIG_SH3_3 | 33 | 39 | PF00018 | 0.567 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.419 |
LIG_SxIP_EBH_1 | 120 | 134 | PF03271 | 0.261 |
LIG_TRAF2_1 | 115 | 118 | PF00917 | 0.373 |
LIG_TRAF2_1 | 155 | 158 | PF00917 | 0.237 |
LIG_TRAF2_1 | 264 | 267 | PF00917 | 0.426 |
LIG_TRAF2_1 | 305 | 308 | PF00917 | 0.296 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.595 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.699 |
MOD_CK2_1 | 112 | 118 | PF00069 | 0.328 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.310 |
MOD_CK2_1 | 265 | 271 | PF00069 | 0.392 |
MOD_CK2_1 | 302 | 308 | PF00069 | 0.296 |
MOD_CK2_1 | 328 | 334 | PF00069 | 0.266 |
MOD_CMANNOS | 109 | 112 | PF00535 | 0.248 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.262 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.230 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.269 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.225 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.657 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.379 |
MOD_N-GLC_1 | 212 | 217 | PF02516 | 0.253 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.259 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.256 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.456 |
MOD_NEK2_1 | 232 | 237 | PF00069 | 0.091 |
MOD_PIKK_1 | 23 | 29 | PF00454 | 0.503 |
MOD_PIKK_1 | 314 | 320 | PF00454 | 0.247 |
MOD_PK_1 | 279 | 285 | PF00069 | 0.350 |
MOD_PKA_1 | 67 | 73 | PF00069 | 0.551 |
MOD_Plk_1 | 265 | 271 | PF00069 | 0.400 |
MOD_Plk_2-3 | 266 | 272 | PF00069 | 0.264 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.266 |
MOD_Plk_4 | 328 | 334 | PF00069 | 0.266 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.222 |
MOD_ProDKin_1 | 244 | 250 | PF00069 | 0.248 |
MOD_ProDKin_1 | 319 | 325 | PF00069 | 0.208 |
MOD_SUMO_rev_2 | 115 | 122 | PF00179 | 0.348 |
TRG_DiLeu_BaEn_2 | 70 | 76 | PF01217 | 0.504 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.248 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.346 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.572 |
TRG_ER_diArg_1 | 295 | 297 | PF00400 | 0.250 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4C8 | Leptomonas seymouri | 77% | 97% |
A0A0S4IKH3 | Bodo saltans | 59% | 99% |
A0A0S4JA19 | Bodo saltans | 35% | 100% |
A0A1X0NJ83 | Trypanosomatidae | 28% | 100% |
A0A1X0NRI1 | Trypanosomatidae | 54% | 93% |
A0A1X0P9A2 | Trypanosomatidae | 25% | 100% |
A0A3Q8IE71 | Leishmania donovani | 36% | 100% |
A0A3Q8IIZ5 | Leishmania donovani | 25% | 100% |
A0A3R7N7B2 | Trypanosoma rangeli | 25% | 100% |
A0A3S7X4R5 | Leishmania donovani | 100% | 100% |
A0A3S7X4T7 | Leishmania donovani | 97% | 100% |
A0A422N418 | Trypanosoma rangeli | 61% | 99% |
A4HH09 | Leishmania braziliensis | 35% | 100% |
A4HJK3 | Leishmania braziliensis | 76% | 100% |
A4HJK8 | Leishmania braziliensis | 83% | 100% |
A4HJL5 | Leishmania braziliensis | 76% | 100% |
A4HM74 | Leishmania braziliensis | 26% | 100% |
A4I438 | Leishmania infantum | 35% | 100% |
A4I4U5 | Leishmania infantum | 25% | 100% |
A4I738 | Leishmania infantum | 91% | 98% |
A9JS71 | Xenopus laevis | 26% | 100% |
C9ZKS4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
C9ZME0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 73% |
C9ZWP5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 96% |
E9ADK3 | Leishmania major | 34% | 100% |
E9AE93 | Leishmania major | 26% | 100% |
E9AEL3 | Leishmania major | 26% | 100% |
E9ALJ3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AM78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9B226 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9B233 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 97% |
E9B5S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
O07137 | Mycobacterium leprae (strain TN) | 25% | 100% |
O35459 | Mus musculus | 23% | 100% |
P14604 | Rattus norvegicus | 24% | 100% |
P23965 | Rattus norvegicus | 39% | 100% |
P30084 | Homo sapiens | 23% | 100% |
P34559 | Caenorhabditis elegans | 21% | 100% |
P42125 | Mus musculus | 39% | 100% |
P42126 | Homo sapiens | 34% | 100% |
P52046 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 21% | 100% |
P64017 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 22% | 100% |
P76082 | Escherichia coli (strain K12) | 24% | 100% |
P94549 | Bacillus subtilis (strain 168) | 27% | 100% |
P9WNN8 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 22% | 100% |
P9WNN9 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 22% | 100% |
Q0AVM1 | Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) | 23% | 100% |
Q13011 | Homo sapiens | 25% | 100% |
Q1ZXF1 | Dictyostelium discoideum | 27% | 100% |
Q4Q628 | Leishmania major | 85% | 100% |
Q4Q636 | Leishmania major | 95% | 100% |
Q52995 | Rhizobium meliloti (strain 1021) | 22% | 100% |
Q58DM8 | Bos taurus | 24% | 100% |
Q5R646 | Pongo abelii | 23% | 100% |
Q5RFG0 | Pongo abelii | 26% | 100% |
Q62651 | Rattus norvegicus | 22% | 100% |
Q8BH95 | Mus musculus | 24% | 100% |
V5B2L9 | Trypanosoma cruzi | 58% | 88% |
V5BK92 | Trypanosoma cruzi | 31% | 100% |
V5DTT7 | Trypanosoma cruzi | 24% | 100% |